(Q46706407)

English

Adverse events and autopsy findings after intravitreous cidofovir (HPMPC) therapy in patients with acquired immune deficiency syndrome (AIDS).

scientific article published in November 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/9373113

Adverse events and autopsy findings after intravitreous cidofovir (HPMPC) therapy in patients with acquired immune deficiency syndrome (AIDS). (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/9373113

1 reference

based on heuristic

inferred from title

author name string

I Taskintuna

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/9373113

F M Rahhal

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/9373113

N A Rao

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/9373113

C A Wiley

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/9373113

A J Mueller

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/9373113

A S Banker

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/9373113

E De Clercq

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/9373113

J F Arevalo

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/9373113

W R Freeman

9

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/9373113

publication date

1 November 1997

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/9373113

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/9373113

104

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/9373113

11

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/9373113

1827-36; discussion 1836-7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/9373113

Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV Retinopathy. Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A Randomized, Controlled Trial of Foscarnet in the Treatment of Cytomegalovirus Retinitis in Patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

(S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel selective broad-spectrum anti-DNA virus agent

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-acting therapy of viral retinitis with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Liposome-encapsulated (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for long-acting therapy of viral retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term therapy for herpes retinitis in an animal model with high-concentrated liposome-encapsulated HPMPC.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravitreal cidofovir for the maintenance treatment of cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of cytomegalovirus retinitis with intravitreous cidofovir in patients with AIDS. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose intravitreal cidofovir (HPMPC) therapy of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Anterior nongranulomatous uveitis after intravitreal HPMPC (cidofovir) for the treatment of cytomegalovirus retinitis. Analysis and prevention.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation between intraocular pressure and CD4+ T-lymphocyte counts in patients with human immunodeficiency virus with and without cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930020-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0161-6420(97)30020-7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/9373113

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/9373113

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46706407&oldid=1400710021"